Neuland Laboratories Limited — Board Meeting, 15-05-2025: Outcome of Board Meeting

Neuland Laboratories has announced a board meeting approving the financial results for the quarter and half-year, with consolidated revenue of ₹14,768 Cr and profit of ₹260 Cr for FY25. An exceptional gain of ₹76 Cr came from selling an investment property. A final dividend of ₹12 per share was approved. Mr. Davuluri Saharsh Rao is set for re-appointment as Vice Chairman & Managing Director for five years, pending shareholder approval. M/s P.S. Rao & Associates were appointed as Secretarial Auditors for five years, also subject to shareholder consent.